openPR Logo
Press release

Retinal Vein Occlusion Market 2023 Analysis - Research Covers Top 10 Players as Allergan, Bayer, GlaxoSmithKline Plc, Novartis, Johnson & Johnson

01-18-2019 06:48 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

/ PR Agency: Market Research Future
Retinal Vein Occlusion Market

Retinal Vein Occlusion Market

Market Highlights

Glaucoma is a condition where the eye pressure causes damage to the optic nerve. The increasing number of patients with glaucoma is leading the retinal vein occlusion market offering a huge growth opportunity to the market players. Moreover, the growing number of patients affected with lymphoma and multiple myeloma is also fueling the growth of the global retinal vein occlusion market.

According to the Centers for Disease Control and Prevention, in 2014, around 47,135 people were diagnosed with leukemia and out of which 23,564 people died from the disease. According to the American Cancer Society, around 4% of all cancers in the United States is lymphoma, additionally, it is estimated that in 2018, about 74,680 people including both adults and children will be diagnosed with lymphoma and around 19,910 people will die from this. According to the American Cancer Society, the risk of acquiring multiple myeloma in the United States is 1 in 143 that is 0.7%, additionally, it is estimated that in 2018, around 30,770 new cases are likely to be diagnosed and the estimated death toll would be around 12,770.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5377

The Global Retinal Vein Occlusion Market is expected to grow at a CAGR of 11.2% during the forecast period 2017-2023.

Major Players in the Retinal Vein Occlusion Market:

Some of the key players in this market are Allergan, Bayer, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Ellex Medical Lasers, GlaxoSmithKline Plc, IRIDEX Corporation, Novartis, Quantel Medical Inc, Topcon Medical Systems, Inc., ZEISS, Lumenis, Sanofi Aventis, Valeant Pharmaceuticals, Alimera Sciences, Fovea Pharmaceuticals SA, Icon Biosciences, Suzuken Co.Ltd, Genentech, Inc., Ranbaxy Pharmaceuticals, Johnson & Johnson Services, Inc, Teva Pharmaceutical, Pfizer Inc., Astrazeneca, Aerpio Therapeutics Inc, Annexin Pharmaceuticals AB and others.

Segmentation:

The global retinal vein occlusion market is segmented on the basis of type, condition, diagnosis, treatment, and end user. On the basis of the type, it is segmented into branch retinal artery occlusion and central retinal vein occlusion. On the basis of the condition, it is segmented into non-ischemic and ischemic. Based on the diagnosis, it is segmented into optical coherence tomography (OCT), fundoscopic examination, fluorescein angiography, and others. On the basis of treatment, it is segmented into antivascular endothelial growth factor, corticosteroid drugs, laser retinal photocoagulation, and others. On the basis of the end users, it is segmented into hospitals and clinics, research & academics centers, and others.

Retinal Vein Occlusion Market Regional Analysis:

The Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of eye diseases. Additionally, high healthcare spending, well-developed technology, and increasing geriatric population will fuel the growth of the market.

The Americas market for retinal vein occlusion is divided into North America and South America. North America holds the major share in the market whereas, South America is showing the fastest growth owing to the presence of a huge opportunity for the development of the market in the region.

The Europe retinal vein occlusion market comprises of Eastern Europe and Western Europe. Western Europe comprises of countries such as Germany, the U.K, France, Italy, and Spain. Europe accounts for the second largest market for the global retinal vein occlusion owing to increasing support from the government, the presence of huge geriatric population, and high healthcare spending. Also, many European countries are trying to encourage the manufacturers for research & development for the introduction of advanced devices. In addition to this, increasing awareness and development in the healthcare infrastructure has provided a push to the growth of the market.

Asia Pacific is the fastest growing market for the global retinal vascular or vein occlusion. Presence of huge patient population, rapid development in technology and presence of a huge opportunity for the development of the market drives the growth of Asia Pacific retinal vascular or vein occlusion market. Also, the government of this region is looking forward to avail better treatment options from developed nations in order to improve the quality of life of their citizens. Additionally, growing geriatric population is also fueling the growth of the market in this region.

On the other hand, the Middle East & Africa holds the least share but will be a fastest growing region in the forecast period. However, due to the presence of poor and slow developing countries, especially, in the African region, it may hold least market share.

Browse Full Reports @ https://www.marketresearchfuture.com/reports/retinal-vein-occlusion-market-5377

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinal Vein Occlusion Market 2023 Analysis - Research Covers Top 10 Players as Allergan, Bayer, GlaxoSmithKline Plc, Novartis, Johnson & Johnson here

News-ID: 1510403 • Views:

More Releases from Market Research Future

Peripheral Nerve Stimulators Market Size, Share | CAGR Of 4.94%
Peripheral Nerve Stimulators Market Size, Share | CAGR Of 4.94%
Peripheral Nerve Stimulators: Transforming Pain Management and Neurological Care Peripheral nerve stimulators (PNS) are emerging as a breakthrough technology in the field of pain management and neurological therapy. These innovative medical devices offer targeted, non-pharmacological treatment options for patients suffering from chronic pain, nerve injuries, and various neurological disorders. As the prevalence of chronic pain conditions continues to rise globally, PNS devices are gaining significant attention from healthcare providers, patients, and
Neurodiagnostics Market Share, Size, Growth Forecast till 2035
Neurodiagnostics Market Share, Size, Growth Forecast till 2035
Neurodiagnostics: Revolutionizing Neurological Healthcare The field of healthcare has witnessed remarkable advancements over the past few decades, and among the most significant is the evolution of neurodiagnostics. Neurodiagnostics refers to the specialized techniques and tools used to assess, monitor, and diagnose disorders of the nervous system. These methods play a critical role in detecting neurological conditions at early stages, improving patient outcomes, and guiding effective treatment strategies. The Neurodiagnostics Market was estimated
Cataract Surgery Device Market Size, Share | CAGR OF 5.22%
Cataract Surgery Device Market Size, Share | CAGR OF 5.22%
Cataract Surgery Devices: Transforming Vision Care and Patient Outcomes Cataract, a condition characterized by the clouding of the eye's natural lens, continues to be one of the leading causes of vision impairment worldwide. With aging populations and increasing prevalence of ocular diseases, the demand for effective and advanced cataract treatment solutions has surged significantly. Central to this evolution is the development and adoption of modern cataract surgery devices, which are redefining
Europe Facial Injectable Market Size Rises at 10.08% CAGR to Capture 0,950.0 Million by 2035
Europe Facial Injectable Market Size Rises at 10.08% CAGR to Capture 0,950.0 Mil …
Europe Facial Injectable Market: Transforming Aesthetic and Rejuvenation Trends The Europe facial injectable market has witnessed remarkable growth in recent years, driven by increasing awareness of cosmetic procedures, evolving aesthetic preferences, and technological advancements in non-invasive treatments. Facial injectables, which primarily include botulinum toxins, dermal fillers, and other neuromodulators, have become a popular choice for individuals seeking facial rejuvenation without undergoing invasive surgery. The shift towards minimally invasive cosmetic procedures has

All 5 Releases


More Releases for America

Stabilit America Highlights Applications of Fiberglass Roof Panels with Stabilit …
Roofing materials are very important in the realm of modern construction, as they should be long lasting, economical and attractive. Fiberglass roof panels are a few of the numerous choices among several alternatives that have received a reputation of being versatile, long life, and adaptable in various sectors. They are favored by the architects, contractors, and property developers due to their lightweight construction, resistance to weather factors, and the ease
Deodorants Market Report by Region (North America, EMEA, Latin America, Asia)
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Deodorants market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound
Sequestrant Market Report by Region (North America, EMEA, Latin America, Asia)
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Sequestrant market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound
Buttermilk Market Study by Region (North America, Latin America, Europe, Asia, M …
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on Buttermilk market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%),
Textiles Market Analysis Report, Regional Outlook - Europe, North America, South …
Adroit Market Research has announced the addition of the “Global Textiles Market Size Status and Forecast 2025”, The report classifies the global Textiles in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Textiles Speaker market, analyzes and researches the Textiles Speaker development status and forecast in Europe, North America, Central America, South America, Asia Pacific
Global Gaucher Disease Market 2018 Covering North America, South America, Europe
Gaucher Disease Market Summary The Global Gaucher Disease Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. Gaucher Disease market size to maintain the average annual growth